News – Page 834 – Endpoints News

Covid-19 roundup: Catalent signs another Covid-19 manufacturing deal; Eli Lilly's antibody partner grabs $175M+

6 years ago

Newron's Merck KGaA-in licensed compound fails Rett Syndrome study, shares wilt

6 years ago

FDA cheers on Gilead's remdesivir with a snap emergency OK, giving biopharma a shot at redemption

6 years ago

EMA gives thumbs up to key drugs from Novartis, Alexion, Vertex and more

6 years ago

Tick saliva-derived drug shows promise in mid-stage rare skin disease study

6 years ago

Bristol Myers Squibb gets priority review for AML drug as list of potential Celgene hits lengthens

6 years ago

High-profile R&D specialist David Lebwohl jumps to new job as CMO of a pioneering CRISPR player; Troubled AMAG ...

6 years ago

Commercial strategy for Gilead's Covid-19 drug-to-be remdesivir remains opaque, as chief O'Day emphasizes ...

6 years ago

Covid-19 roundup: Amgen tosses Otezla into anti-inflammatory mix; Trump thickens plot around US probe into virus ...

6 years ago

Bob Langer-founded Lyra Therapeutics raises $56M in latest high-end biotech IPO

6 years ago

10X: Moderna creates a billion-dose vaccine pact in a frenzied race to beat Covid-19 — globally

6 years ago

After NIH trial, EMA begins rolling review for remdesivir, setting up potential authorizations in US and Europe

6 years ago

Vertex lavishes $80M cash to expand gene therapy tool kit; Supernus bags a $300M CNS portfolio

6 years ago

What does a post-pandemic IPO filing look like? Hong Kong biotech application offers clues

6 years ago

Congressional watchdog advises HHS to implement 'post-marketing' incentives to address dwindling antibiotic ...

6 years ago

Amid Covid-19 hunt, Pfizer adds Lyme disease vaccine in $308M deal with Valneva

6 years ago

Kelly Martin skips to a new CEO suite as his last biotech team raises the white flag

6 years ago

AstraZeneca vaults to the front of the Covid-19 vaccine race, teaming up to globalize Oxford candidate

6 years ago

Covid-19 roundup: GSK CEO Emma Walmsley — some trial delays, but we’re limiting the damage — so far; Trump ...

6 years ago

GSK widens the market for Zejula as FDA signs off on the PARP inhibitor for use in ovarian cancer patients without ...

6 years ago

Data on Gilead's antiviral bring hope for first Covid-19 drug approval

6 years ago

AstraZeneca, GSK reiterate 2020 outlook; Shanghai biotech I-Mab is looking for a US partner — report

6 years ago

The biopharma funding engine motors on, as Chinese biotech raises nearly $280M in monster round

6 years ago

Novartis spinout resTORbio reverse merges with T cell biotech after big PhIII failure

6 years ago

First page Previous page 831 832 833834835 836 837 Next page Last page